The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Safety Lancets for Diabetes Market Research Report 2024
Synopsis
Safety lancets are single-use devices for capillary blood sampling dedicated to healthcare professionals. They are an integral component to the sharps-injury prevention programs in hospitals, clinics, laboratories, doctor’s offices and wherever both patients and professionals need to feel safe. By using safety lancets, needle-stick injuries and infections can be eliminated.
Global Safety Lancets for Diabetes market is projected to reach US$ 738.7 million in 2029, increasing from US$ 517 million in 2022, with the CAGR of 5.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Safety Lancets for Diabetes market research.
The blood collection needle market is driven by the increasing demand for diagnostic testing and the growing prevalence of chronic diseases that require frequent blood sampling. Blood collection needles are essential medical devices used to collect blood samples for various laboratory tests and medical procedures. The rise in the aging population and the need for accurate and efficient blood collection contribute to market growth as these needles play a vital role in healthcare settings. Moreover, advancements in needle technology and the development of safety-engineered needles have improved the safety and comfort of blood collection procedures. However, the market also faces challenges, including the need for proper training and handling of needles to prevent accidental needlestick injuries. Additionally, addressing regulatory compliance and ensuring the availability of quality and sterile blood collection needles can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and user-friendly blood collection needles, collaborate with healthcare institutions to improve blood collection practices, and address the challenges to meet the increasing demand for reliable and safe blood sampling solutions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Safety Lancets for Diabetes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
BD
Ascensia
Lifescan
B. Braun
Terumo
Nipro
Cardinal Health
ARKRAY
ICU Medical
Owen Mumford
HemoCue
Greiner Bio One
HTL-STREFA
Sarstedt
Segment by Type
Safety Lancets with Needle
Safety Lancets with Blade
Segment by Application
Hospital & Clinics
Home
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Safety Lancets for Diabetes report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Safety lancets are single-use devices for capillary blood sampling dedicated to healthcare professionals. They are an integral component to the sharps-injury prevention programs in hospitals, clinics, laboratories, doctor’s offices and wherever both patients and professionals need to feel safe. By using safety lancets, needle-stick injuries and infections can be eliminated.
Global Safety Lancets for Diabetes market is projected to reach US$ 738.7 million in 2029, increasing from US$ 517 million in 2022, with the CAGR of 5.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Safety Lancets for Diabetes market research.
The blood collection needle market is driven by the increasing demand for diagnostic testing and the growing prevalence of chronic diseases that require frequent blood sampling. Blood collection needles are essential medical devices used to collect blood samples for various laboratory tests and medical procedures. The rise in the aging population and the need for accurate and efficient blood collection contribute to market growth as these needles play a vital role in healthcare settings. Moreover, advancements in needle technology and the development of safety-engineered needles have improved the safety and comfort of blood collection procedures. However, the market also faces challenges, including the need for proper training and handling of needles to prevent accidental needlestick injuries. Additionally, addressing regulatory compliance and ensuring the availability of quality and sterile blood collection needles can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and user-friendly blood collection needles, collaborate with healthcare institutions to improve blood collection practices, and address the challenges to meet the increasing demand for reliable and safe blood sampling solutions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Safety Lancets for Diabetes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
BD
Ascensia
Lifescan
B. Braun
Terumo
Nipro
Cardinal Health
ARKRAY
ICU Medical
Owen Mumford
HemoCue
Greiner Bio One
HTL-STREFA
Sarstedt
Segment by Type
Safety Lancets with Needle
Safety Lancets with Blade
Segment by Application
Hospital & Clinics
Home
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Safety Lancets for Diabetes report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Safety Lancets for Diabetes Market Overview
1.1 Product Overview and Scope of Safety Lancets for Diabetes
1.2 Safety Lancets for Diabetes Segment by Type
1.2.1 Global Safety Lancets for Diabetes Market Value Comparison by Type (2023-2029)
1.2.2 Safety Lancets with Needle
1.2.3 Safety Lancets with Blade
1.3 Safety Lancets for Diabetes Segment by Application
1.3.1 Global Safety Lancets for Diabetes Market Value by Application: (2023-2029)
1.3.2 Hospital & Clinics
1.3.3 Home
1.3.4 Other
1.4 Global Safety Lancets for Diabetes Market Size Estimates and Forecasts
1.4.1 Global Safety Lancets for Diabetes Revenue 2018-2029
1.4.2 Global Safety Lancets for Diabetes Sales 2018-2029
1.4.3 Global Safety Lancets for Diabetes Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Safety Lancets for Diabetes Market Competition by Manufacturers
2.1 Global Safety Lancets for Diabetes Sales Market Share by Manufacturers (2018-2023)
2.2 Global Safety Lancets for Diabetes Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Safety Lancets for Diabetes Average Price by Manufacturers (2018-2023)
2.4 Global Safety Lancets for Diabetes Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Safety Lancets for Diabetes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Safety Lancets for Diabetes, Product Type & Application
2.7 Safety Lancets for Diabetes Market Competitive Situation and Trends
2.7.1 Safety Lancets for Diabetes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Safety Lancets for Diabetes Players Market Share by Revenue
2.7.3 Global Safety Lancets for Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Safety Lancets for Diabetes Retrospective Market Scenario by Region
3.1 Global Safety Lancets for Diabetes Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Safety Lancets for Diabetes Global Safety Lancets for Diabetes Sales by Region: 2018-2029
3.2.1 Global Safety Lancets for Diabetes Sales by Region: 2018-2023
3.2.2 Global Safety Lancets for Diabetes Sales by Region: 2024-2029
3.3 Global Safety Lancets for Diabetes Global Safety Lancets for Diabetes Revenue by Region: 2018-2029
3.3.1 Global Safety Lancets for Diabetes Revenue by Region: 2018-2023
3.3.2 Global Safety Lancets for Diabetes Revenue by Region: 2024-2029
3.4 North America Safety Lancets for Diabetes Market Facts & Figures by Country
3.4.1 North America Safety Lancets for Diabetes Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Safety Lancets for Diabetes Sales by Country (2018-2029)
3.4.3 North America Safety Lancets for Diabetes Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Safety Lancets for Diabetes Market Facts & Figures by Country
3.5.1 Europe Safety Lancets for Diabetes Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Safety Lancets for Diabetes Sales by Country (2018-2029)
3.5.3 Europe Safety Lancets for Diabetes Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Safety Lancets for Diabetes Market Facts & Figures by Country
3.6.1 Asia Pacific Safety Lancets for Diabetes Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Safety Lancets for Diabetes Sales by Country (2018-2029)
3.6.3 Asia Pacific Safety Lancets for Diabetes Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Safety Lancets for Diabetes Market Facts & Figures by Country
3.7.1 Latin America Safety Lancets for Diabetes Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Safety Lancets for Diabetes Sales by Country (2018-2029)
3.7.3 Latin America Safety Lancets for Diabetes Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Safety Lancets for Diabetes Market Facts & Figures by Country
3.8.1 Middle East and Africa Safety Lancets for Diabetes Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Safety Lancets for Diabetes Sales by Country (2018-2029)
3.8.3 Middle East and Africa Safety Lancets for Diabetes Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Safety Lancets for Diabetes Sales by Type (2018-2029)
4.1.1 Global Safety Lancets for Diabetes Sales by Type (2018-2023)
4.1.2 Global Safety Lancets for Diabetes Sales by Type (2024-2029)
4.1.3 Global Safety Lancets for Diabetes Sales Market Share by Type (2018-2029)
4.2 Global Safety Lancets for Diabetes Revenue by Type (2018-2029)
4.2.1 Global Safety Lancets for Diabetes Revenue by Type (2018-2023)
4.2.2 Global Safety Lancets for Diabetes Revenue by Type (2024-2029)
4.2.3 Global Safety Lancets for Diabetes Revenue Market Share by Type (2018-2029)
4.3 Global Safety Lancets for Diabetes Price by Type (2018-2029)
5 Segment by Application
5.1 Global Safety Lancets for Diabetes Sales by Application (2018-2029)
5.1.1 Global Safety Lancets for Diabetes Sales by Application (2018-2023)
5.1.2 Global Safety Lancets for Diabetes Sales by Application (2024-2029)
5.1.3 Global Safety Lancets for Diabetes Sales Market Share by Application (2018-2029)
5.2 Global Safety Lancets for Diabetes Revenue by Application (2018-2029)
5.2.1 Global Safety Lancets for Diabetes Revenue by Application (2018-2023)
5.2.2 Global Safety Lancets for Diabetes Revenue by Application (2024-2029)
5.2.3 Global Safety Lancets for Diabetes Revenue Market Share by Application (2018-2029)
5.3 Global Safety Lancets for Diabetes Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Safety Lancets for Diabetes Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BD Safety Lancets for Diabetes Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Ascensia
6.3.1 Ascensia Corporation Information
6.3.2 Ascensia Description and Business Overview
6.3.3 Ascensia Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ascensia Safety Lancets for Diabetes Product Portfolio
6.3.5 Ascensia Recent Developments/Updates
6.4 Lifescan
6.4.1 Lifescan Corporation Information
6.4.2 Lifescan Description and Business Overview
6.4.3 Lifescan Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lifescan Safety Lancets for Diabetes Product Portfolio
6.4.5 Lifescan Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Corporation Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.5.4 B. Braun Safety Lancets for Diabetes Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Terumo Safety Lancets for Diabetes Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 Nipro
6.6.1 Nipro Corporation Information
6.6.2 Nipro Description and Business Overview
6.6.3 Nipro Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nipro Safety Lancets for Diabetes Product Portfolio
6.7.5 Nipro Recent Developments/Updates
6.8 Cardinal Health
6.8.1 Cardinal Health Corporation Information
6.8.2 Cardinal Health Description and Business Overview
6.8.3 Cardinal Health Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cardinal Health Safety Lancets for Diabetes Product Portfolio
6.8.5 Cardinal Health Recent Developments/Updates
6.9 ARKRAY
6.9.1 ARKRAY Corporation Information
6.9.2 ARKRAY Description and Business Overview
6.9.3 ARKRAY Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.9.4 ARKRAY Safety Lancets for Diabetes Product Portfolio
6.9.5 ARKRAY Recent Developments/Updates
6.10 ICU Medical
6.10.1 ICU Medical Corporation Information
6.10.2 ICU Medical Description and Business Overview
6.10.3 ICU Medical Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.10.4 ICU Medical Safety Lancets for Diabetes Product Portfolio
6.10.5 ICU Medical Recent Developments/Updates
6.11 Owen Mumford
6.11.1 Owen Mumford Corporation Information
6.11.2 Owen Mumford Safety Lancets for Diabetes Description and Business Overview
6.11.3 Owen Mumford Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Owen Mumford Safety Lancets for Diabetes Product Portfolio
6.11.5 Owen Mumford Recent Developments/Updates
6.12 HemoCue
6.12.1 HemoCue Corporation Information
6.12.2 HemoCue Safety Lancets for Diabetes Description and Business Overview
6.12.3 HemoCue Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.12.4 HemoCue Safety Lancets for Diabetes Product Portfolio
6.12.5 HemoCue Recent Developments/Updates
6.13 Greiner Bio One
6.13.1 Greiner Bio One Corporation Information
6.13.2 Greiner Bio One Safety Lancets for Diabetes Description and Business Overview
6.13.3 Greiner Bio One Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Greiner Bio One Safety Lancets for Diabetes Product Portfolio
6.13.5 Greiner Bio One Recent Developments/Updates
6.14 HTL-STREFA
6.14.1 HTL-STREFA Corporation Information
6.14.2 HTL-STREFA Safety Lancets for Diabetes Description and Business Overview
6.14.3 HTL-STREFA Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.14.4 HTL-STREFA Safety Lancets for Diabetes Product Portfolio
6.14.5 HTL-STREFA Recent Developments/Updates
6.15 Sarstedt
6.15.1 Sarstedt Corporation Information
6.15.2 Sarstedt Safety Lancets for Diabetes Description and Business Overview
6.15.3 Sarstedt Safety Lancets for Diabetes Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Sarstedt Safety Lancets for Diabetes Product Portfolio
6.15.5 Sarstedt Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Safety Lancets for Diabetes Industry Chain Analysis
7.2 Safety Lancets for Diabetes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Safety Lancets for Diabetes Production Mode & Process
7.4 Safety Lancets for Diabetes Sales and Marketing
7.4.1 Safety Lancets for Diabetes Sales Channels
7.4.2 Safety Lancets for Diabetes Distributors
7.5 Safety Lancets for Diabetes Customers
8 Safety Lancets for Diabetes Market Dynamics
8.1 Safety Lancets for Diabetes Industry Trends
8.2 Safety Lancets for Diabetes Market Drivers
8.3 Safety Lancets for Diabetes Market Challenges
8.4 Safety Lancets for Diabetes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
